ARQT Competitors & Alternatives
Compare Arcutis Biotherapeutics Inc with similar stocks in the same industry
Biotechnology
ARQT
Main Stock$23.89
Tradestie Score
53
Market Cap
$2.37B
P/E Ratio
106.3
Revenue Growth
0.6%
Analyst Upside
+54.4%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$22.80
|
$3.31B | - | 41 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$28.20
|
$3.09B | - | 33 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$31.98
|
$3.08B | - | 50 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 48 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$58.65
|
$3.02B | - | 52 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$72.35
|
$3.01B | - | 46 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 50 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$14.30
|
$2.89B | - | 49 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$37.36
|
$2.85B | - | 42 | Compare |
More ARQT Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry